Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

118 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Tumor suppressor role of phospholipase C epsilon in Ras-triggered cancers.
Martins M, McCarthy A, Baxendale R, Guichard S, Magno L, Kessaris N, El-Bahrawy M, Yu P, Katan M. Martins M, et al. Among authors: guichard s. Proc Natl Acad Sci U S A. 2014 Mar 18;111(11):4239-44. doi: 10.1073/pnas.1311500111. Epub 2014 Mar 3. Proc Natl Acad Sci U S A. 2014. PMID: 24591640 Free PMC article.
Expression pattern of the FoxO1 gene during mouse embryonic development.
Villarejo-Balcells B, Guichard S, Rigby PW, Carvajal JJ. Villarejo-Balcells B, et al. Among authors: guichard s. Gene Expr Patterns. 2011 Jun-Jul;11(5-6):299-308. doi: 10.1016/j.gep.2011.02.002. Epub 2011 Mar 10. Gene Expr Patterns. 2011. PMID: 21397048
FT-4202, a selective pyruvate kinase R activator for sickle cell disease.
Ericsson A, Richard DJ, Wilker E, Lancia JDR, Fessler S, Troccolo P, Zheng X, Toms A, Dinsmore C, Yao L, Kuypers FA, Larkin S, Marcotte D, Fulzele K, Ribadeneira M, Guichard SM, Marshall G. Ericsson A, et al. Among authors: guichard sm. Exp Hematol. 2024 Nov 14:104673. doi: 10.1016/j.exphem.2024.104673. Online ahead of print. Exp Hematol. 2024. PMID: 39549740 Free article.
FT-6876, a Potent and Selective Inhibitor of CBP/p300, is Active in Preclinical Models of Androgen Receptor-Positive Breast Cancer.
Caligiuri M, Williams GL, Castro J, Battalagine L, Wilker E, Yao L, Schiller S, Toms A, Li P, Pardo E, Graves B, Azofeifa J, Chicas A, Herbertz T, Lai M, Basken J, Wood KW, Xu Q, Guichard SM. Caligiuri M, et al. Among authors: guichard sm. Target Oncol. 2023 Mar;18(2):269-285. doi: 10.1007/s11523-023-00949-7. Epub 2023 Feb 24. Target Oncol. 2023. PMID: 36826464 Free PMC article.
118 results